Real-time enrollment status for this myeloproliferative neoplasms (mpns) clinical trial
Current Status
Recruiting
Checked: October 27, 2026 at 5:34 PM UTC
| NCT Number | NCT07849231 |
| Recruiting Status | Recruiting |
| Condition | Myeloproliferative Neoplasms (MPNs) |
| Phase | PHASE1 |
| Target Enrollment | 250 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Damora Therapeutics |
| Last Updated on CT.gov | October 27, 2026 (17 hours ago) |
As of October 27, 2026: Clinical trial NCT07849231 is currently recruiting participants. This phase1 study for myeloproliferative neoplasms (mpns) is actively seeking new participants at 25 locations across the United States. The study is sponsored by Damora Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07849231 is actively recruiting participants as of October 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07849231 was last updated 17 hours ago (October 27, 2026). HelloStudys verifies this status automatically.